Aurachin D

Aurachin D

SCHEMBL16552860

CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)[nH]c2ccccc2c1=O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.64
▸ VKORC1 Q9BQB6 1/20 0.55
▸ HTT P42858 1/20 0.52
▸ PGR P06401 1/20 0.49
▸ HTR1A P08908 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ PTGS1 P23219 1/20 0.49
▸ PDE4A P27815 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ SNCA P37840 1/20 0.49
▸ PDE3A Q14432 1/20 0.49
▸ PTPN1 P18031 1/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ MAOA P21397 1/20 0.45
▸ HSD17B10 Q99714 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PPARG P37231 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aurachin D SCHEMBL29456185 1.00 SLC2A1 (0.64) SLC2A1VKORC1HTTPGRHTR1A
Aurachin D SCHEMBL15094902 1.00 SLC2A1 (0.64) SLC2A1VKORC1HTTPGRHTR1A
SCHEMBL14519803 0.82 CYP2D6 (0.53) SLC2A1VKORC1PGRHTR1AADORA3
SCHEMBL16431075 0.82 CYP2D6 (0.53) SLC2A1VKORC1PGRHTR1AADORA3
SCHEMBL9597639 0.79 VKORC1 (0.51) VKORC1PGRHTR1AADORA3MAPT
Aurachin E SCHEMBL29885181 0.77 VKORC1 (0.48) SLC2A1VKORC1PGRHTR1AADORA3
Aurachin E SCHEMBL29392647 0.77 VKORC1 (0.48) SLC2A1VKORC1PGRHTR1AADORA3
SCHEMBL17866868 0.76 VKORC1 (0.48) VKORC1PGRHTR1AADORA3MAPT
SCHEMBL14519808 0.76 VKORC1 (0.48) VKORC1PGRHTR1AADORA3MAPT
Aurachin C SCHEMBL15094711 0.75 VKORC1 (0.54) VKORC1PGRHTR1AADORA3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117883436-B Use of endoperoxides alone or in combination with respiratory chain inhibitors for the preparation of antibacterial agents 中国科学院深圳先进技术研究院 2025-05-02 — — CN disclosed
CN-117883436-A Use of endoperoxides alone or in combination with respiratory chain inhibitors for the preparation of antibacterial agents 中国科学院深圳先进技术研究院 2024-04-16 — — CN disclosed
US-20150071904-A1 COMPOSITIONS AND METHODS TO BOOST ENDOGENOUS ROS PRODUCTION FROM BACTERIA TRUSTEES OF BOSTON UNIVERSITY 2015-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150071904-A1 COMPOSITIONS AND METHODS TO BOOST ENDOGENOUS ROS PRODUCTION FROM BACTERIA ROS1, NOX4, CYBB SLC2A1 2716/4885VKORC1 3532/4885HTT 4322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback